Newswires
No comments
PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19: Coronavirus – COVID-19
Vaccine Daily
2021 OCT 27 (NewsRx) -- By a
As a matter of record, on
Tracking Information
| Trial Identifier | NCT05075941 |
| First Submitted Date | |
| First Posted Date | |
| Results First Submitted Date | Not Provided |
| Results First Posted Date | Not Provided |
| Last Update Submitted Date | |
| Last Update Posted Date | |
| Primary Completion Date | |
| Start Date | |
| Current Primary Outcome Measures | •Vaccination coverage among COVID-19 [ Time Frame: one month ] -- Assess the proportion of people declaring to have received at least one dose of vaccination against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing |
| •Identify the most appropriate conditions for the use of vaccination against COVID-19 [ Time Frame: one month ] -- Promote interventions to encourage the use of COVID-19 vaccination | |
| Current Secondary Outcome Measures | Not Provided |
| Other Outcome Measures | Not Provided |
| Change History | Complete list of historical revisions of study NCT05075941 |
Descriptive Information
| Brief Title | Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations |
| Official Title | PREVAC: Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 |
| Brief Summary | The main objective of the study is to assess the level of vaccination coverage (VC) against COVID-19 among migrants, homeless and travelling community, according to their living conditions and housing. The secondary objectives are : - to compare the estimated level of vaccination coverage in the different sites and strata (emergency shelters/hotels, camps, workers’ hostels, on the street) with the estimated level in the general population of the same territory obtained from the |
| Detailed Description | Not Provided |
| Study Type | Observational |
| Study Phase | Not Provided |
| Study Design | Observational Model: Other |
| Time Perspective: Cross-Sectional | |
| Condition | COVID-19 |
| Intervention | •Other: Vaccination coverage |
| proportion of people declaring to have received at least one dose of vaccination against COVID-19 among target population | |
| Study Arms | •Covid Homeless and migrants |
| Interventions: | |
| ⚬Other: Vaccination coverage | |
| •Shelters Paris/93 | |
| Interventions: | |
| ⚬Other: Vaccination coverage | |
| •Street/Camps Paris/93 | |
| Interventions: | |
| ⚬Other: Vaccination coverage | |
| •Workers’ hostels |
|
| Interventions: | |
| ⚬Other: Vaccination coverage | |
| •travelling community IDF(77/93/95) | |
| Interventions: | |
| ⚬Other: Vaccination coverage |
Recruitment Information
| Recruitment Status | Not yet recruiting |
| Estimated Enrollment | 3470 |
| Estimated Completion Date | |
| Primary Completion Date | |
| Eligibility | Inclusion Criteria: |
| •Adult (18 years and older) | |
| •People considered as homeless (homeless, living in a camp or squat) or | |
| •Living in adapted housing (migrant workers’ hostel) or | |
| •Housed in residences of the National System or | |
| •Housed in a social residence such as a 115 hotel or a social housing centre | |
| •Freely and voluntarily consenting to participate Exclusion Criteria: | |
| •Refusal to participate in the study (non-consent). | |
| •Language barrier with no in-person or telephone translation available. | |
| •Impossibility to give free and informed consent (comprehension barrier, cognitive and/or psychiatric and/or addictive disorders, external pressure from family and friends, persons under guardianship, etc.). | |
| Sex/Gender | Sexes Eligible for Study: All |
| Ages | 18 years and older |
| Not Provided | |
| Contacts | Primary contact: Thomas ROEDERER, +33 1 40 21 55 55, [email protected] |
| Backup contact: Jessica SAYYAD, +33 1 40 21 55 55, [email protected] | |
| Listed Location Countries | Not Provided |
| Removed Location Countries |
Administrative Information
| NCT Number | NCT05075941 |
| Other Study ID Numbers | 2021-A01960-41 |
| Has Data Monitoring Committee | Not Provided |
| Not Provided | |
| Plan to Share Data | Yes |
| Plan to Share Data (IPD) Description | The results will be presented in a report to the Ministry of Health, the Haute Autorite de |
| Epicentre | |
| Collaborators | ⚬SANTE PUBLIQUE |
| ⚬Medecins Sans Frontieres, |
|
| ⚬Medecins du Monde | |
| ⚬CROIX ROUGE FRANCAISE | |
| ⚬OBSERVATOIRE DU SAMU SOCIAL | |
| ⚬INTERLOGEMENT 93 | |
| ⚬Agence Regionale de |
|
| Investigators | Principal Investigator: Elisabeth POULET, MD, Epicentre |
| Information Provided By | Epicentre |
| Verification Date |
(Our reports deliver fact-based news of research and discoveries from around the world.)
Riverside Health System enters health insurance business with launch of Medicare supplement plan [Daily Press]
Fort Worth Health Insurance Sees Massive Overhaul In Seven Ways With New Spending Bill
Advisor News
- Can a balance of withdrawals and annuities outshine the 4% rule?
- Economy ‘in a sweet spot’ but some concerns ahead
- Trump, Capitol allies likely looking at quick cryptocurrency legislation
- SEC panel reviews mandatory arbitration clause in investment advisory agreements
- Financial shocks, caregiving, inflation and technology are top retirement concerns
More Advisor NewsAnnuity News
Health/Employee Benefits News
- Thousands to lose health insurance at major Mass. hospital systems as of Jan. 1
- Hospital association points to insurers for ongoing financial woes post-COVID
- Mangione faces federal charges in New York after extradition from Blair County
- What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices for everyone
- Suspect in UnitedHealth executive killing faces federal murder, stalking charges
More Health/Employee Benefits NewsLife Insurance News